Fetalifetech develops fetaLife, a liquid incubator that immerses extremely premature infants (≤26 weeks gestation) in a sterile, temperature‑controlled fluid environment that mimics the womb. The system provides closed‑loop oxygenation, carbon‑dioxide removal, and real‑time monitoring of vital signs, reducing invasive ventilation and infection risk while supporting a smoother transition to conventional NICU care.
Funding
Funding not disclosed
Founders
Product
Problem
Extremely premature infants (born at or before 26 weeks gestation) face high mortality and severe complications because current neonatal intensive care units cannot fully replicate the protective environment of the womb.
Solution
fetaLife offers a liquid incubator that sustains premature newborns in a fluid-filled environment mimicking key physiological conditions of the maternal uterus. The system provides controlled temperature, oxygenation, and nutrient delivery while reducing exposure to invasive ventilation and infection risks. By maintaining a womb-like milieu, the technology aims to improve survival rates and long-term health outcomes for the most vulnerable infants.
Target Audience
Primary users are neonatal intensive care units and specialized perinatal centers that treat infants born at ≤26 weeks gestation.
Features
- Closed-loop fluidic chamber that immerses the infant in a sterile, temperature‑regulated liquid medium
- Integrated oxygenation and carbon‑dioxide removal system to maintain optimal gas exchange
- Continuous monitoring of vital signs with real‑time feedback control for temperature, pH, and electrolyte balance
- Modular design allowing gradual transition to conventional NICU care as the infant matures
- Compatibility with existing neonatal support equipment and bedside monitoring infrastructure